Prevalence of inducible AmpC β-lactamase-producing Pseudomonas aeruginosa in a tertiary care hospital in northern India [1]

Indian Journal of Medical Microbiology

Volumn 26, Issue 1, 2008, Pages 89-90

  Bhattacharjee, A ^a   Anupurba, S ^a   Gaur, A ^a   Sen, M ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CARBAPENEM; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; NETILMICIN; PIPERACILLIN PLUS TAZOBACTAM; SULBACTAM; SULPERAZON; TAZOBACTAM; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; BACTERIUM DETECTION; BACTERIUM ISOLATION; BLOOD; DISC ANTAGONISM TEST; DRUG INACTIVATION; DRUG SCREENING; EPIDEMIC; HOSPITAL INFECTION; HUMAN; INDUCIBLE AMPC BETA LACTAMASE PRODUCING PSEUDOMONAS AERUGINOSA; INFECTION SENSITIVITY; LETTER; MICROBIAL SENSITIVITY TEST; PATHOGENESIS; PREVALENCE; PSEUDOMONAS AERUGINOSA; PUS; SAMPLING; TERTIARY HEALTH CARE; TREATMENT FAILURE; URINE;

EID: 38849176845     PISSN: 02550857     EISSN: 02550857     Source Type: Journal    
DOI: 10.4103/0255-0857.38872     Document Type: Letter

References (5)

1. Shahid M, Malik A, Sheeba. Multidrug - resistant Pseudomonas aeruginosa strains harboring R - plasmids and AmpC β-lactamases isolated from hospitalized burn patients in a tertiary care hospital of North India. FEMS Microbiol Let 2003;223:147-51.
2. CLSI. Performance standards for antimicrobial disc susceptibility tests. CLSI: Wayne PA; 2005. p. M100-S15.
3. Shahid S, Malik A, Agrawal M, Singhal S. Phenotypic detection of extended spectrum and AmpC β -lactamases by a new spot inoculation method and modified three dimensional extract test: Comparison with the conventional three-dimensional extract test. J Antimicrob Chemother 2004;54:684-7.
4. Arora S, Bal M. AmpC β-lactamases producing bacterial isolates from Kolkatta hospital. Indian J Med Res 2005;122: 224-33.
5. Anupurba S, Sen MR. Antimicrobial resistance profile of bacterial isolates from Intensive Care Unit: Changing trends. J Commun Dis 2005;37:58-65.